June 15, 2020
June 15, 2020 – The U.S. FDA has revoked its Emergency Use Authorization (EUA) for oral formulations of
chloroquine and hydroxychloroquine to be used as potential treatments for COVID-19
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
June 12, 2020
June 12, 2020 – The U.S. FDA has approved UpliznaTM (inebilizumab-cdon), manufactured by Viela Bio, to
treat neuromyelitis optica spectrum disorder (NMOSD) in adults who test positive
June 12, 2020
June 12, 2020 – The U.S. FDA has approved Tivicay® PD (dolutegravir) tablets for oral suspension,
manufactured by ViiV Healthcare, for use in combination with other
May 21, 2020
May 21, 2020 – Here you will find some of new approval and lunched latest drug news. Please read some of news together here at our news section.
May 20, 2020
May 20, 2020 The U.S. FDA has approved a new indication for Lynparza® (olaparib), manufactured by
AstraZeneca and Merck, to treat adult patients who have deleterious or suspected deleterious germline
May 15, 2020
May 15, 2020 – The U.S. FDA has approved a new indication for Pomalyst® (pomalidomide), manufactured
by Bristol Myers Squibb. It is indicated to treat AIDS-related Kaposi sarcoma
May 15, 2020
May 15, 2020 – The U.S. FDA has approved QinlockTM (ripretinib), manufactured by Deciphera
Pharmaceuticals, to treat adult patients who have advanced gastrointestinal
May 15, 2020
May 15, 2020 – The U.S. FDA has approved a new indication for Rubraca® (rucaparib), manufactured by
Clovis Oncology. Rubraca is now indicated to treat adult patients who have